Summit Therapeutics (SMMT) Operating Income Growth (3y) (2022 - 2024)
Summit Therapeutics (SMMT) Operating Income Growth (3y) (2022 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 55.96% |
| 10 | Summit Therapeutics | 10.52 Bn | 9.83 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -36.06% |
| Sep 30, 2024 | -44.16% |
| Jun 30, 2024 | -35.94% |
| Mar 31, 2024 | -35.81% |
| Dec 31, 2023 | -46.33% |
| Sep 30, 2023 | -6.55% |
| Jun 30, 2023 | -0.94% |
| Mar 31, 2023 | -286.00% |
| Dec 31, 2022 | 21.00% |
| Sep 30, 2022 | -39.88% |
| Mar 31, 2022 | 0.29% |